Your browser doesn't support javascript.
loading
Supplementation with Bifidobacterium longum subspecies infantis EVC001 for mitigation of type 1 diabetes autoimmunity: the GPPAD-SINT1A randomised controlled trial protocol.
Ziegler, Anette-Gabriele; Arnolds, Stefanie; Kölln, Annika; Achenbach, Peter; Berner, Reinhard; Bonifacio, Ezio; Casteels, Kristina; Elding Larsson, Helena; Gündert, Melanie; Hasford, Joerg; Kordonouri, Olga; Lundgren, Markus; Oltarzewski, Mariusz; Pekalski, Marcin L; Pfirrmann, Markus; Snape, Matthew D; Szypowska, Agnieszka; Todd, John A.
Afiliação
  • Ziegler AG; Institute of Diabetes Research, Helmholtz Zentrum München, Neuherberg, Germany anette-g.ziegler@helmholtz-muenchen.de.
  • Arnolds S; Forschergruppe Diabetes, Klinikum rechts der Isar, Technische Universität München, Medical Faculty, Munich, Germany.
  • Kölln A; Institute of Diabetes Research, Helmholtz Zentrum München, Neuherberg, Germany.
  • Achenbach P; Institute of Diabetes Research, Helmholtz Zentrum München, Neuherberg, Germany.
  • Berner R; Institute of Diabetes Research, Helmholtz Zentrum München, Neuherberg, Germany.
  • Bonifacio E; Forschergruppe Diabetes, Klinikum rechts der Isar, Technische Universität München, Medical Faculty, Munich, Germany.
  • Casteels K; Department of Pediatrics, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Elding Larsson H; Center for Regenerative Therapies Dresden (CRTD), Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
  • Gündert M; Department of Pedriatrics, University Hospitals Leuven, Leuven, Belgium.
  • Hasford J; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
  • Kordonouri O; Department of Paediatrics, Skåne University Hospital, Malmö, Sweden.
  • Lundgren M; Department of Paediatrics, Skåne University Hospital Lund, Lund, Sweden.
  • Oltarzewski M; Institute of Diabetes Research, Helmholtz Zentrum München, Neuherberg, Germany.
  • Pekalski ML; Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Pfirrmann M; Kinder- und Jugendkrankenhaus AUF DER BULT, Hannover, Germany.
  • Snape MD; Department of Paediatrics, Skåne University Hospital, Malmö, Sweden.
  • Szypowska A; Institute of Mother and Child, Warszawa, Poland.
  • Todd JA; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
BMJ Open ; 11(11): e052449, 2021 11 09.
Article em En | MEDLINE | ID: mdl-34753762
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Microbioma Gastrointestinal Tipo de estudo: Clinical_trials Aspecto: Ethics Limite: Child / Humans / Infant Idioma: En Revista: BMJ Open Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Microbioma Gastrointestinal Tipo de estudo: Clinical_trials Aspecto: Ethics Limite: Child / Humans / Infant Idioma: En Revista: BMJ Open Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido